Online ISSN: 3007-0244,
Print ISSN:  2410-4280
VESTA SYNDROME: ETIOLOGY AND EARLY DIAGNOSTIC SIGNS. LITERATURE REVIEW
Introduction: Hypsarrhythmia is manifested by chaotic asynchronous spikes with a high amplitude, mainly with slow-wave activity. This electroencephalographic pattern was first noted among a large number of patients with infantile spasms. The triad of symptoms: infantile spasms, delayed psychomotor development and hypsarrhythmia on electroencephalography was called West syndrome, which has a gradual development both in healthy children and against the background of psychomotor delay. West's syndrome is a severe variant of epileptic diseases in children due to complex therapeutic tactics and impaired mental development. Determination of etiological causes and early diagnostic signs contributes to a more accurate prognosis and choice of therapy. Objective: analyze and systematize publications devoted to the study of the etiology and early diagnostic signs of West syndrome. Results: In the scientific literature, along with the diagnosis of West syndrome, terms such as infantile spasms or epileptic spasms are used. In recent years, significant advances have been made in all significant and less common aspects of the disorder, including its nomenclature, etiology, associated genetic factors, clinical diversity and complex phenotypes, as well as treatment and prognosis. West syndrome is characterized by a combination of cluster spasms, hypsarrhythmia on an electroencephalogram, and psychomotor regression. Treatment should be started as soon as possible after diagnosis, especially during infancy, to maximize seizure control and improve long-term outcomes. Conclusions: Predictors of an unfavorable outcome of West syndrome can be considered: the structural and genetic form of the disease, neonatal seizures, the presence of epileptiform activity on electroencephalography, impaired neuropsychic development and the presence of focal pathology before spasms, the presence of seizures other than spasms, persistence of epileptiform activity in dynamics, ineffectiveness of the first therapy lines.
Bibigul A. Abdygalyk1, https://orcid.org/0000-0001-8171-6112 Nazira A. Zharkinbekova2, https://orcid.org/0000-0002-5069-1562 Marzhan M. Lepesova3, Latina A. Tekebaeva1, Elena D. Belousova4 1 Kazakhstan Medical University “KSPH”, Almaty c., Republic of Kazakhstan; 2 South Kazakhstan Medical Academy, Shymkent c., Republic of Kazakhstan; 3 Kazakh medical university of continuing education, Almaty c., Republic of Kazakhstan; 4 The Scientific Research Institute of Pediatrics of the Russian National Research Medical University named N.I. Pirogov, the Department of Psychoneurology and Epileptology, Moscow с., Russian Federation.
1. Прыгунова Т.М., Антипенко Е.А., Мухин К.Ю. Предикторы неблагоприятного исхода синдрома Веста // Аспирантский вестник Поволжья. 2020. №1–2. С. 68–74. https://doi.org/10.17816/2072-2354.2020.20.1.68-74 2. Синдром Веста [Электронный ресурс]. URL: http://epidoc.ru/syndromes/ilae/west_syndrome.html (дата обращения: 13.05.2021). 3. Al Dhaibani M.A., El-Hattab A.W., Ismayl O., Suleiman J. B3GALNT2 - Related Dystroglycanopathy: Expansion of the Phenotype with Novel Mutation Associated with Muscle-Eye-Brain Disease, Walker-Warburg Syndrome, Epileptic Encephalopathy-West Syndrome, and Sensorineural Hearing Loss // Neuropediatrics. 2018. № 4(49). С. 289–295. DOI:10.1055/s-0038-1651519. 4. Appleton R.E. West syndrome: Long-term prognosis and social aspects // Brain and Development. 2001. № 7(23). С. 688–691. DOI:10.1016/S0387-7604(01)00264-9. 5. Alrifai M.T., Alshaya M.A., Abulaban A., Alfadhel M. Hereditary neurometabolic causes of infantile spasms in 80 children presenting to a tertiary care center // Pediatric Neurology. 2014. № 3(51). С. 390–397. DOI:10.1016/j.pediatrneurol.2014.05.015. 6. Atlas of Electroencephalography // Neurology. 1954. № 4(4). С. 321–321. DOI:10.1212/wnl.4.4.321. 7. Auvin S., Hartman A.L., Desnous B., Moreau A.C., Alberti C., Delanoe C., Romano A., Terrone G., Kossoff E.H., Del Giudice E., Titomanlio L. Diagnosis delay in West syndrome: Misdiagnosis and consequences // European Journal of Pediatrics. 2012. № 11(171). С. 1695–1701. DOI:10.1007/s00431-012-1813-6. 8. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009 // Epilepsia. 2010. № 4(51). С. 676–685. DOI:10.1111/j.1528-1167.2010.02522.x. 9. Caraballo R.H., Ruggieri V., Gonzalez G., Cersósimo R., Gamboni B., Rey A., Poveda J.C.P., Dalla Bernardina B. Infantile spams without hypsarrhythmia: A study of 16 cases // Seizure. 2011. № 3(20). С. 197–202. DOI:10.1016/j.seizure.2010.11.018 10. Cerminara C., Compagnone E., Bagnolo V., Galasso C., Lo-Castro A., Brinciotti M., Curatolo P. Late-onset epileptic spasms in children with pallister-killian syndrome: A report of two new cases and review of the electroclinical aspects // Journal of Child Neurology. 2010. № 2(25). С. 238–245. DOI:10.1177/0883073809336933. 11. Chiron C., Dulac O., Luna D., Palacios L., Mondragon S., Beaumont D., Mumford J.P. Vigabatrin in infantile spasms. № 8685(335)Elsevier, 10.02.1990. 12. Chugani H.T., Shields W.D., Shewmon D.A., Olson D.M., Phelps M.E., Peacock W.J. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment // Annals of Neurology. 1990. № 4(27). С. 406–413. DOI:10.1002/ana.410270408. 13. Commission on Classification and Terminology of the... - Академия Google [Электронный ресурс]. URL: https://scholar.google.com/scholar_lookup?title=Proposal for revised classification of epilepsies and epileptic syndromes&journal=Epilepsia&volume=30&pages=389-399&publication_year=1989 (дата обращения: 13.05.2021). 14. Conroy J., Allen N.M., Gorman K., O’Halloran E., et al. Novel European SLC1A4 variant: Infantile spasms and population ancestry analysis // Journal of Human Genetics. 2016. № 8(61). С. 761–764. DOI:10.1038/jhg.2016.44. 15. Coppola G., Grosso S., Verrotti A., D’Aniello A., Pascotto A. Simultaneous Onset of Infantile Spasms in Monozygotic Twins // Pediatric Neurology. 2010. № 2(43). С. 127–130. DOI:10.1016/j.pediatrneurol.2010.04.010. 16. Daida A., Hamano S. ichiro, Ikemoto S., Matsuura R., Nakashima M., Matsumoto N., Kato M. Biallelic loss-of-function UBA5 mutations in a patient with intractable West syndrome and profound failure to thrive // Epileptic Disorders. 2018. № 4(20). С. 313–318. DOI:10.1684/epd.2018.0981. 17. D’Alonzo R., Rigante D., Mencaroni E., Esposito S. West Syndrome: A Review and Guide for Paediatricians. № 2(38)Springer International Publishing, 01.02.2018. 18. Donner M. Incidence and Aetiology of Infantile Spasms from 1960 to 1976: a Population Study in Finland // Developmental Medicine & Child Neurology. 1979. № 3(21). С. 333–343. DOI:10.1111/j.1469-8749.1979.tb01625.x. 19. Dulac O., Feingold J., Plouin P., Chiron C., Pajot N., Ponsot G. Genetic Predisposition to West Syndrome // Epilepsia. 1993. № 4(34). С. 732–737. DOI:10.1111/j.1528-1157.1993.tb00454.x. 20. Elia M., Falco M., Ferri R., Spalletta A., Bottitta M., Calabrese G., Carotenuto M., Musumeci S.A., Lo Giudice M., Fichera M. CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy // Neurology. 2008. № 13(71). С. 997–999. DOI:10.1212/01.wnl.0000326592.37105.88. 21. Faulkner M.A., Tolman J.A. Safety and Efficacy of Vigabatrin for the Treatment of Infantile Spasms // Journal of Central Nervous System Disease. 2011. (3). С. JCNSD.S6371. DOI:10.4137/jcnsd.s6371. 22. Fisher R.S., Cross J.H., French J.A., Higurashi N., Hirsch E., et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology // Epilepsia. 2017. № 4(58). С. 522–530. DOI:10.1111/epi.13670. 23. Gaily E., Jonsson H., Lappi M. Visual fields at school-age in children treated with vigabatrin in infancy // Epilepsia. 2009. № 2(50). С. 206–216. DOI:10.1111/j.1528-1167.2008.01961.x. 24. Gastaut H., Roger J., Soulayrol R., Salamon G., Regis H., Lob H. Encéphalopathie myoclonique infantile avec hypsarythmie (syndrome de West) et sclérose tubéreuse de Bourneville // Journal of the Neurological Sciences. 1965. № 2(2). С. 140–160. DOI:10.1016/0022-510X(65)90077-8. 25. Ghosh S., Rao P. High-Dose-Rate Orthogonal Intracavitary Brachytherapy with 9 Gy/Fraction in Locally Advanced Cervical Cancer: Is it Feasible?? // The Journal of Obstetrics and Gynecology of India. 2016. № S1(66). С. 452–458. DOI:10.1007/s13224-015-0812-8. 26. Go C.Y., MacKay M.T., Weiss S.K., Stephens D., Adams-Webber T., Ashwal S., Snead O.C. Evidence-based guideline update: Medical treatment of infantile spasms: Report of the guideline development subcommittee of the American academy of neurology and the practice committee of the child neurology society // Neurology. 2012. № 24(78). С. 1974–1980. DOI:10.1212/WNL.0b013e318259e2cf. 27. Goh S., Kwiatkowski D.J., Dorer D.J., Thiele E.A. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex // Neurology. 2005. № 2(65). С. 235–238. DOI:10.1212/01.wnl.0000168908.78118.99. 28. Gram L., Sabers A., Dulac O. Treatment of pediatric epilepsies with γ-vinyl GABA (vigabatrin) // Epilepsia. 1992. (33 Suppl 5). С. S26-9. 29. Guerrini R., Filippi T. Topical Review: Neuronal Migration Disorders, Genetics, and Epileptogenesis // Journal of Child Neurology. 2004. № 3(19). С. 287–299. DOI:10.1177/08830738040190030401. 30. Gullotta F., Pavone L., Mollica F., Grasso S., Valenti C. Krabbe’s disease with unusual clinical and morphological features // Neuropadiatrie. 1979. № 4(10). С. 395–400. DOI:10.1055/s-0028-1085341. 31. Guzzetta F. Cognitive and behavioral outcome in West syndrome // Epilepsia. 2006. № SUPPL. 2(47). С. 49–52. DOI:10.1111/j.1528-1167.2006.00689.x. 32. Hamada N., Ogaya S., Nakashima M., Nishijo T., Sugawara Y., Iwamoto I., Ito H., Maki Y., Shirai K., Baba S., Maruyama K., Saitsu H., Kato M., Matsumoto N., Momiyama T., Nagata K.I. De novo PHACTR1 mutations in West syndrome and their pathophysiological effects // Brain. 2018. № 11(141). С. 3098–3114. DOI:10.1093/brain/awy246. 33. Hemminki K., Li X., Johansson S.E., Sundquist K., Sundquist J. Familial risks for epilepsy among siblings based on hospitalizations in Sweden // Neuroepidemiology. 2006. № 2(27). С. 67–73. DOI:10.1159/000094976. 34. Jdila M. Ben, Triki C., Rhouma B. Ben, Jomaa R. Ben, Issa A. Ben, Ammar-Keskes L., Kamoun F., Fakhfakh F. A novel C-terminal truncated mutation in hCDKL5 protein causing a severe West syndrome: Comparison with previous truncated mutations and genotype/phenotype correlation // International Journal of Developmental Neuroscience. 2019. (72). С. 22–30. DOI:10.1016/j.ijdevneu.2018.09.006. 35. Jia J.L., Chen S., Sivarajah V., Stephens D., Cortez M.A. Latitudinal differences on the global epidemiology of infantile spasms: Systematic review and meta-analysis. № 1(13)BioMed Central Ltd., 29.11.2018. 36. Jones K., Weiss S.K., Minassian B. Infantile spasms with periventricular nodular heterotopia, unbalanced chromosomal translocation 3p26.2 ‐10p15.1 and 6q22.31 duplication // Clinical Case Reports. 2016. № 7(4). С. 675–677. DOI:10.1002/ccr3.591. 37. Kato M., Das S., Petras K., Sawaishi Y., Dobyns W.B. Polyalanine expansion of ARX associated with cryptogenic West syndrome // Neurology. 2003. № 2(61). С. 267–268. DOI:10.1212/01.wnl.0000068012.69928.92. 38. Karvelas G., Lortie A., Scantlebury M.H., Duy P.T., Cossette P., Carmant L. A retrospective study on aetiology based outcome of infantile spasms // Seizure. 2009. № 3(18). С. 197–201. DOI:10.1016/j.seizure.2008.09.006. 39. Kivity S., Lerman P., Ariel R., Danziger Y., Mimouni M., Shinnar S. Long-term Cognitive Outcomes of a Cohort of Children with Cryptogenic Infantile Spasms Treated with High-dose Adrenocorticotropic Hormone // Epilepsia. 2004. № 3(45). С. 255–262. DOI:10.1111/j.0013-9580.2004.30503.x. 40. Lee H.H., Hur Y.J. Glucose transport 1 deficiency presenting as infantile spasms with a mutation identified in exon 9 of SLC2A1 // Korean Journal of Pediatrics. 2016. № Suppl 1(59). С. S29–S31. DOI:10.3345/kjp.2016.59.11.S29. 41. Lux A.L., Osborne J.P. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: Consensus statement of the West Delphi Group // Epilepsia. 2004. № 11(45). С. 1416–1428. DOI:10.1111/j.0013-9580.2004.02404.x. 42. Lux A.L., Edwards S.W., Hancock E., Johnson A.L., Kennedy C.R., Newton R.W., O’Callaghan F.J.K., Verity C.M., Osborne J.P. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: A multicentre randomised trial // Lancet Neurology. 2005. № 11(4). С. 712–717. DOI:10.1016/S1474-4422(05)70199-X. 43. Lux A.L. Latest American and European updates on infantile spasms // Current Neurology and Neuroscience Reports. 2013. № 3(13). С. 1–8. DOI:10.1007/s11910-012-0334-z. 44. Mackay M.T., Weiss S.K., Adams-Webber T., et al. Practice parameter: Medical treatment of infantile spasms: Report of the American Academy of Neurology and the Child Neurology Society. № 10(62)Lippincott Williams and Wilkins, 25.05.2004. 45. Marshall C.R., Young E.J., Pani A.M., Freckmann M.L., et al. Infantile Spasms Is Associated with Deletion of the MAGI2 Gene on Chromosome 7q11.23-q21.11 // American Journal of Human Genetics. 2008. № 1(83). С. 106–111. DOI:10.1016/j.ajhg.2008.06.001. 46. Millichap J.J., Miceli F., De Maria M., Keator C., Joshi N., Tran B., Soldovieri M.V., Ambrosino P., Shashi V., Mikati M.A., Cooper E.C., Taglialatela M. Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant // Epilepsia. 2017. № 1(58). С. e10–e15. DOI:10.1111/epi.13601. 47. Morikawa M., Takano K., Motobayashi M., Shiba N., Kosho T., Nakazawa Y., Inaba Y. Clinical features of a female with WDR45 mutation complicated by infantile spasms: a case report and literature review // Brain and Development. 2017. № 9(39). С. 804–807. DOI:10.1016/j.braindev.2017.05.003. 48. Mytinger J.R., Weber A., Heyer G.L. The response to ACTH is determined early in the treatment of infantile spasms // Epileptic Disorders. 2015. № 1(17). С. 52–57. DOI:10.1684/epd.2014.0723. 49. Nakashima M., Takano K., Tsuyusaki Y., Yoshitomi S., et al. WDR45 mutations in three male patients with West syndrome // Journal of Human Genetics. 2016. № 7(61). С. 653–661. DOI:10.1038/jhg.2016.27. 50. Nakano T., Kato S., Ohno T., Tsujii H., Sato S., Fukuhisa K., Arai T. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix // Cancer. 2005. № 1(103). С. 92–101. DOI:10.1002/cncr.20734. 51. Neville B.G.R. The Origin of Infantile Spasms: Evidence from a Case of Hydranencephaly // Developmental Medicine & Child Neurology. 1972. № 5(14). С. 644–647. DOI:10.1111/j.1469-8749.1972.tb02647.x. 52. Ngoh A., Bras J., Guerreiro R., Meyer E., McTague A., et al. RARS2 mutations in a sibship with infantile spasms // Epilepsia. 2016. № 5(57). С. e97–e102. DOI:10.1111/epi.13358. 53. Ohtahara S. Seizure disorders in infancy and childhood // Brain and Development. 1984. № 6(6). С. 511–519. DOI:10.1016/S0387-7604(84)80094-7. 54. Paciorkowski A.R., Thio L.L., Dobyns W.B. Genetic and biologic classification of infantile spasms. № 6(45)Elsevier, 01.12.2011. 55. Pavone L., Mollica F., Incorpora G., Pampiglione G. Infantile spasms syndrome in monozygotic twins. A 7-year follow-up // The Italian Journal of Neurological Sciences. 1985. № 4(6). С. 503–506. DOI:10.1007/BF02331045. 56. Pavone P., Striano P., Falsaperla R., Pavone L., Ruggieri M. Infantile spasms syndrome, West syndrome and related phenotypes: What we know in 2013. № 9(36)Elsevier, 01.10.2014. 57. Pavone P., Polizzi A., Marino S.D., Corsello G., Falsaperla R., Marino S., Ruggieri M. West syndrome: a comprehensive review. № 12(41)Springer-Verlag Italia s.r.l., 01.12.2020. 58. Peng J., Wang Y., He F., Chen C., Wu L.W., et al. Novel West syndrome candidate genes in a Chinese cohort // CNS Neuroscience and Therapeutics. 2018. № 12(24). С. 1196–1206. DOI:10.1111/cns.12860. 59. Pereira A.G., Bahi-Buisson N., Barnerias C., Boddaert N., Nabbout R., de Lonlay P., Kaminska A., Eisermann M. Epileptic spasms in congenital disorders of glycosylation // Epileptic Disorders. 2017. № 1(19). С. 15–23. DOI:10.1684/epd.2017.0901 60. Pellock J.M., Hrachovy R., Shinnar S., Baram T.Z., et al. Infantile spasms: A U.S. consensus report. № 10(51)John Wiley & Sons, Ltd, 01.10.2010. 61. Primec Z.R., Stare J., Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration // Epilepsia. 2006. № 12(47). С. 2202–2205. DOI:10.1111/j.1528-1167.2006.00888.x. 62. Rantala H., Putkonen T. Occurrence, outcome, and prognostic factors of infantile spasms and Lennox-Gastaut syndrome // Epilepsia. 1999. № 3(40). С. 286–289. DOI:10.1111/j.1528-1157.1999.tb00705.x. 63. Riikonen R., Rener-Primec Z., Carmant L., et al. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study // Developmental Medicine and Child Neurology. 2015. № 1(57). С. 60–67. DOI:10.1111/dmcn.12573. 64. Scheffer I.E., Berkovic S., Capovilla G., Connolly M.B., et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology // Epilepsia. 2017. № 4(58). С. 512–521. DOI:10.1111/epi.13709. 65. Smpokou P., Samanta M., Berry G.T., Hecht L., Engle E.C., Lichter-Konecki U. Menkes disease in affected females: The clinical disease spectrum // American Journal of Medical Genetics, Part A. 2015. № 2(167). С. 417–420. DOI:10.1002/ajmg.a.36853. 66. Solomon D., Davey D., Kurman R., Members the F.G., et al. The Bethesda 2001 workshop. The 2001 Bethesda system: terminology for reporting results of cervical cytology // JAMA. 2002. (287). С. 2114–2119. 67. Takezawa Y., Fujie H., Kikuchi A., Niihori T., et al. Novel IARS2 mutations in Japanese siblings with CAGSSS, Leigh, and West syndrome // Brain and Development. 2018. № 10(40). С. 934–938. DOI:10.1016/j.braindev.2018.06.010. 68. Tanzi R.E., Petrukhin K., Chernov I., Pellequer J.L., et al. The Wilson disease gene is a copper transporting ATPase with homology to the menkes disease gene // Nature Genetics. 1993. № 4(5). С. 344–350. DOI:10.1038/ng1293-344. 69. Tapp S., Anderson T., Visootsak J. Neurodevelopmental Outcomes in Children with Down Syndrome and Infantile Spasms // Journal of Pediatric Neurology. 2015. № 2(13). С. 74–77. DOI:10.1055/s-0035-1556768. 70. Tian G., Cristancho A.G., Dubbs H.A., Liu G.T., Cowan N.J., Goldberg E.M. A patient with lissencephaly, developmental delay, and infantile spasms, due to de novo heterozygous mutation of KIF2A // Molecular Genetics and Genomic Medicine. 2016. № 6(4). С. 599–603. DOI:10.1002/mgg3.236. 71. Van Karnebeek C.D.M., Tiebout S.A., Niermeijer J., et al. Pyridoxine-Dependent Epilepsy: An Expanding Clinical Spectrum. (59)Elsevier Inc., 01.06.2016. 72. Vigevano F., Cilio M.R. Vigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized, prospective study // Epilepsia. 1997. № 12(38). С. 1270–1274. DOI:10.1111/j.1528-1157.1997.tb00063.x. 73. Wanigasinghe J., Arambepola C., Sri Ranganathan S., Sumanasena S., Muhandiram E.C. The efficacy of moderate-to-high dose oral prednisolone versus low-to-moderate dose intramuscular corticotropin for improvement of hypsarrhythmia in west syndrome: A randomized, single-blind, parallel clinical trial // Pediatric Neurology. 2014. № 1(51). С. 24–30. DOI:10.1016/j.pediatrneurol.2014.03.014. 74. Wallerstein R., Sugalski R., Cohn L., Jawetz R., Friez M. Expansion of the ARX spectrum // Clinical Neurology and Neurosurgery. 2008. № 6(110). С. 631–634. DOI:10.1016/j.clineuro.2008.03.007. 75. Weaving L.S., Christodoulou J., Williamson S.L., et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation // American Journal of Human Genetics. 2004. № 6(75). С. 1079–1093. DOI:10.1086/426462. 76. West W.J. ON A peculiar form of infantile convulsions // Elsevier. № 911(35). 13.02.1841. 77. Westall C.A., Wright T., Cortese F., Kumarappah A., Snead O.C., Buncic J.R. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study // Neurology. 2014. № 24(83). С. 2262–2268. DOI:10.1212/WNL.0000000000001069. 78. Widjaja E., Go C., McCoy B., Snead Oc.C. Neurodevelopmental outcome of infantile spasms: A systematic review and meta-analysis // Epilepsy Research. 2015. № 1(109). С. 155–162. DOI:10.1016/j.eplepsyres.2014.11.012. 79. Wong M., Trevathan E. Infantile spasms. // Pediatr Neurol, 2001. № 2(24) 80. Yamada K., Toribe Y., Kimizu T., Kimura S., Ikeda T., Mogami Y., Yanagihara K., Mano T., Suzuki Y. Predictive value of EEG findings at control of epileptic spasms for seizure relapse in patients with West syndrome // Seizure. 2014. № 9(23). С. 703–707. DOI:10.1016/j.seizure.2014.05.010. Reference [1,2]: 1. Prygunova T.M., Antipenko E.A., Mukhin K.Yu. Prediktory neblagopriyatnogo iskhoda sindroma Vesta [Predictors of an unfavorable outcome of the West syndrome]. Aspirantskii vestnik Povolzh'ya [Postgraduate Bulletin of the Volga Region]. 2020. №1–2. pp.68–74. https://doi.org/10.17816/2072-2354.2020.20.1.68-74 [in Russian] 2. Sindrom Vesta [West syndrome] [Elektronnyi resurs]. URL:http://epidoc.ru/syndromes/ilae/west_syndrome.html (accessed: 13.05.2021). [in Russian]
Number of Views: 132

Key words:

Category of articles: Reviews

Bibliography link

Abdygalyk B.A., Zharkinbekova N.A., Lepesova M.M., Tekebaeva L.A., Belousova E.D. Vesta syndrome: etiology and early diagnostic signs. Literature review // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 1, pp. 157-166. doi 10.34689/SH.2022.24.1.018

Авторизируйтесь для отправки комментариев